In KRAS-mutant colorectal cancer cells, inhibition of the Nrf2/HO-1 axis contributed to the promotion of ferroptosis induced by RSL3, a GPX4 inhibitor (Yang et al., 2021). This evidence concerns the gene KRAS and colorectal cancer.